Triad Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Triad Wealth Partners's LLY Position: Q3 2026 in Review
Triad Wealth Partners increased its Eli Lilly (LLY) stake by 4.2% in Q3 2026, buying an estimated $211K and bringing the position to 4,485 shares worth $5.19M. The position accounts for 0.29% of the portfolio, ranked #56.
Triad Wealth Partners first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Triad Wealth Partners held 4,485 shares of Eli Lilly worth $5.19M as of Q3 2026.
- Triad Wealth Partners bought 179 Eli Lilly shares in Q3 2026, an estimated $211K.
- Eli Lilly made up 0.29% of Triad Wealth Partners's portfolio in Q3 2026, its #56 holding.
- Triad Wealth Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Triad Wealth Partners's 13F filing for Q3 2026, filed 26 Oct 2026.